402 related articles for article (PubMed ID: 26973393)
1. Synergistic anticancer properties of docosahexaenoic acid and 5-fluorouracil through interference with energy metabolism and cell cycle arrest in human gastric cancer cell line AGS cells.
Gao K; Liang Q; Zhao ZH; Li YF; Wang SF
World J Gastroenterol; 2016 Mar; 22(10):2971-80. PubMed ID: 26973393
[TBL] [Abstract][Full Text] [Related]
2. [Effect of combination of docosahexaenoic acid and fluorouracil on human gastric carcinoma cell strain MGC803].
Wu Q; Yu JC; Liu YQ; Kang WM; Guo WD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Feb; 32(1):65-70. PubMed ID: 20236591
[TBL] [Abstract][Full Text] [Related]
3. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells.
Najafzadeh N; Mazani M; Abbasi A; Farassati F; Amani M
Biomed Pharmacother; 2015 Aug; 74():243-51. PubMed ID: 26349992
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of c-Myc and p21 expression and induction of S phase arrest by naphthalene diimide derivative in gastric adenocarcinoma cells.
Gurung SK; Dana S; Mandal K; Mukhopadhyay P; Mondal N
Chem Biol Interact; 2019 May; 304():106-123. PubMed ID: 30840857
[TBL] [Abstract][Full Text] [Related]
5. Lentivirus-mediated shRNA targeting of cyclin D1 enhances the chemosensitivity of human gastric cancer to 5-fluorouracil.
Seo JH; Jeong ES; Lee KS; Heo SH; Jeong DG; Choi YK
Int J Oncol; 2013 Dec; 43(6):2007-14. PubMed ID: 24100731
[TBL] [Abstract][Full Text] [Related]
6. The effect of combination treatment with docosahexaenoic acid and 5-fluorouracil on the mRNA expression of apoptosis-related genes, including the novel gene BCL2L12, in gastric cancer cells.
Zhuo Z; Zhang L; Mu Q; Lou Y; Gong Z; Shi Y; Ouyang G; Zhang Y
In Vitro Cell Dev Biol Anim; 2009; 45(1-2):69-74. PubMed ID: 19015929
[TBL] [Abstract][Full Text] [Related]
7. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
8. Synergistic enhancement of the antitumor activity of 5-fluorouracil by bornyl acetate in SGC-7901 human gastric cancer cells and the determination of the underlying mechanism of action.
Li J; Wang SX
J BUON; 2016; 21(1):108-17. PubMed ID: 27061538
[TBL] [Abstract][Full Text] [Related]
9. The Ω-3 fatty acid docosahexaenoic acid selectively induces apoptosis in tumor-derived cells and suppress tumor growth in gastric cancer.
Ortega L; Lobos-González L; Reyna-Jeldes M; Cerda D; De la Fuente-Ortega E; Castro P; Bernal G; Coddou C
Eur J Pharmacol; 2021 Apr; 896():173910. PubMed ID: 33508285
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antitumor effect of 3-bromopyruvate and 5-fluorouracil against human colorectal cancer through cell cycle arrest and induction of apoptosis.
Chong D; Ma L; Liu F; Zhang Z; Zhao S; Huo Q; Zhang P; Zheng H; Liu H
Anticancer Drugs; 2017 Sep; 28(8):831-840. PubMed ID: 28816773
[TBL] [Abstract][Full Text] [Related]
11. LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells.
Shin JY; Kim JO; Lee SK; Chae HS; Kang JH
BMC Cancer; 2010 Aug; 10():425. PubMed ID: 20704765
[TBL] [Abstract][Full Text] [Related]
12. Nobiletin induces apoptosis and potentiates the effects of the anticancer drug 5-fluorouracil in p53-mutated SNU-16 human gastric cancer cells.
Moon JY; Cho M; Ahn KS; Cho SK
Nutr Cancer; 2013; 65(2):286-95. PubMed ID: 23441616
[TBL] [Abstract][Full Text] [Related]
13. Rofecoxib augments anticancer effects by reversing intrinsic multidrug resistance gene expression in BGC-823 gastric cancer cells.
Zhu FS; Chen XM; Huang ZG; Wang ZR; Zhang DW; Zhang X
J Dig Dis; 2010 Feb; 11(1):34-42. PubMed ID: 20132429
[TBL] [Abstract][Full Text] [Related]
14. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein.
He WT; Zhu YH; Zhang T; Abulimiti P; Zeng FY; Zhang LP; Luo LJ; Xie XM; Zhang HL
Chin J Integr Med; 2019 Jun; 25(6):416-424. PubMed ID: 30484020
[TBL] [Abstract][Full Text] [Related]
15. Effects of 5-fluouracil combined with sulfasalazine on human pancreatic carcinoma cell line BxPC-3 proliferation and apoptosis in vitro.
Huang Z; Guo KJ; Guo RX; He SG
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):312-20. PubMed ID: 17548258
[TBL] [Abstract][Full Text] [Related]
16. Contribution of Epstein-Barr virus infection to chemoresistance of gastric carcinoma cells to 5-fluorouracil.
Seo JS; Kim TG; Hong YS; Chen JY; Lee SK
Arch Pharm Res; 2011 Apr; 34(4):635-43. PubMed ID: 21544729
[TBL] [Abstract][Full Text] [Related]
17. Cell Cycle Arrest and Apoptosis Induction of Phloroacetophenone Glycosides and Caffeoylquinic Acid Derivatives in Gastric Adenocarcinoma (AGS) Cells.
Jafari N; Zargar SJ; Delnavazi MR; Yassa N
Anticancer Agents Med Chem; 2018; 18(4):610-616. PubMed ID: 29256356
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits the growth of AGS human gastric carcinoma cells in vitro and shows synergism with 5-fluorouracil.
Koo JY; Kim HJ; Jung KO; Park KY
J Med Food; 2004; 7(2):117-21. PubMed ID: 15298755
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil.
Calviello G; Di Nicuolo F; Serini S; Piccioni E; Boninsegna A; Maggiano N; Ranelletti FO; Palozza P
Cancer Chemother Pharmacol; 2005 Jan; 55(1):12-20. PubMed ID: 15365767
[TBL] [Abstract][Full Text] [Related]
20. Cell Cycle Dysregulation Is Associated With 5-Fluorouracil Resistance in Gastric Cancer Cells.
Kim DS; Min K; Lee SK
Anticancer Res; 2020 Jun; 40(6):3247-3254. PubMed ID: 32487619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
